
Metabolic & fat loss
Semaglutide
A universal weight-loss drug for anyone wanting to be leaner
THE EVIDENCE-GRADED DIRECTORY
Showing 6 of 30 profiles
All learning goals · Evidence grades are not treatment rankings.
Metabolic & fat loss
A universal weight-loss drug for anyone wanting to be leaner

Metabolic & fat loss
That higher dose is always better

Metabolic & fat loss
That it should be combined with another GLP-1 drug

Metabolic & fat loss
General obesity treatment

Metabolic & fat loss
Use for ordinary obesity

Metabolic & fat loss
Long-term benefit-risk outside trials
Vial images are illustrative concepts, not products offered for sale or evidence of approval or availability.
Select up to 3 profiles. Selection is preserved when you change filters.
YOUR LEARNING STARTING POINT
Choose an area to explore. This changes your reading path, not a treatment recommendation.
No health history needed. Filters and comparison choices appear in the shareable page URL, not your account. Keep search terms educational; do not enter personal health details.
SIDE BY SIDE
Compare the research context, not which peptide you should take. Studies may involve different conditions and populations; this is not a head-to-head trial or a safety ranking.
This atlas covers peptides commonly marketed in the U.S. biohacking, telehealth, cosmetic and research-chemical ecosystem, plus clinically important approved peptide therapies. It is not every peptide drug used across all of medicine. Profiles carry their own recorded review dates. Some content dates to July 2026; this is not a continuously verified regulatory database. Check the linked official record before relying on an approval or access claim.



HOW TO USE THIS PAGE
Choose the clinical or performance question before choosing a molecule.
Approval, human evidence, formulation and dose context are separate questions.
Bring the exact product, claim, risks, monitoring plan and safer alternatives into the conversation.
*Approval applies only to the specific indication, formulation, population and dose described in the prescribing information—not every wellness claim attached to the molecule.
01 / BROWSE BY GOAL
STATUS KEY
FDA reviewed a specific product for a specific indication. Off-label wellness claims may still be unsupported.
Legitimate access may be limited to registered clinical trials.
Topical or oral consumer use does not establish injectable safety.
Being sold online or compounded does not make a product approved.
02 / READ THE RESEARCH
Useful for mechanism and toxicity questions. It cannot establish a consumer treatment.
Usually explores safety, pharmacology and dose—not whether a wellness claim works.
Tests the intervention in people with the target condition and continues safety work.
Larger studies test whether benefits hold up against a comparator and reveal more harms.
Review applies to a defined product, indication and label; monitoring continues after launch.
Evidence grades are editorial summaries for the context described, not a formal systematic review or clinician endorsement. Approval and evidence certainty are separate: accelerated approval can rely on an intermediate endpoint, with confirmatory evidence still required. Source counts include different kinds of links and are not a quality score.
04 / REAL-WORLD CHECKS
Use FDA’s BeSafeRx tools before purchasing prescription medicine online.
Open FDA BeSafeRx ↗ATHLETESCheck sport status.Many peptide hormones, growth factors and related substances are prohibited. Search the exact active ingredient and confirm with your governing body.
Open Global DRO ↗REPORTDocument a serious problem.FDA MedWatch accepts reports about serious reactions, product-quality problems, use errors and therapeutic failures.
Open FDA MedWatch ↗Competitive-sport rules change and can be substance-, route- and timing-specific. The 2026 WADA Prohibited List is in force; Global DRO is a medication-status reference, not a substitute for your anti-doping organization.
BEFORE ANY PEPTIDE
Brand, molecule, salt or analog, concentration, route and lot.
Approved product, lawful compounding need, clinical trial or gray market.
Meaningful outcomes in people—not only animal mechanisms or testimonials.
Diagnosis, contraindications, medication interactions and monitoring plan.
What success means, when to reassess and which symptoms mean stop.
THE EVIDENCE-GRADED DIRECTORY
A field guide to the peptides most often discussed in metabolic health, recovery, skin, energy, cognition, sexual health and immune care—with evidence limits, risks and linked references.
Explore 30 peptide profiles
01 / EXPLORE THE ATLAS
THE MODERN BIO STANDARD
YOUR NEXT STEP
Clinical review determines the appropriate next step. No treatment is guaranteed.
THE CARE PATH
We order your labs
A licensed clinician reviews results and recommends a plan
Rx sent directly to you when appropriate
Care depends on eligibility and clinical judgment. No prescription is guaranteed. This pathway is not a recommendation for the treatment or test discussed in this guide.
Start your lab reviewExplore free educational tools